E129: Long Term Routine Laboratory Monitoring in RA

E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)

E127: TNFs and All That CHF

E126: Risk Signals, JAKs, and SELECTIVE-ity

E125: Adrenal Insufficiency after Stopping Prednisone

e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study

E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA

E122: Guidelines for Maybe Diagnosing HLH

E121: Obinutuzumab in SLE-LN

E120: Real Life Use of PEXIVAS-Low

E119: Teclistamab for Rheumatology Writ Large

E118: The emerging risk of overdiagnosis in RA and PMR

E117: Inebilizumab for IgG4-RD (MITIGATE)

E116: A New Paradigm for PMR

E115: Benralizumab for EGPA - the MANDARA Study

E114: Target Trials and STAR-RA with Rishi Desai

E113: CAR-T is Coming to Rheumatology

E112: Gabapentin is Trash

E111: PEXIVAS Subsets with Mike Walsh & Mats Junek

E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson